Role of bilevel positive airway pressure in the management of preterm newborns who have received surfactant
- 29 October 2010
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 99 (12) , 1807-1811
Abstract
Aim: Surfactant given during brief intubation followed by immediate extubation on nasal continuous positive airway pressure [Intubation‐Surfactant‐Extubation (InSurE) approach] is used to treat respiratory distress syndrome in newborns. Our aim was to evaluate whether bilevel positive airway pressure (BiPAP) after InSurE failure is able to prevent the need for mechanical ventilation (MV).Methods: Chart data of infants with a birth weight Results: Six of twenty‐two (27%) and 14 of the 38 (37%) infants failed InSurE in the two groups, respectively (p > 0.05). Need for MV was 27% in the historical control group versus 0% in the BiPAP group (risk estimate, 3.38; 95% CI, 2.24, 5.09; p = 0.001).Conclusions: BiPAP reduced the need for MV after InSurE failure.Keywords
This publication has 22 references indexed in Scilit:
- To tube or not to tube babies with respiratory distress syndromeJournal of Perinatology, 2009
- Continuous Positive Airway Pressure and SurfactantNeonatology, 2008
- Optimal Ventilatory Strategies and Surfactant to Protect the Preterm LungsNeonatology, 2008
- Implementation of surfactant treatment during continuous positive airway pressureJournal of Perinatology, 2007
- Surfactant Administration by Transient Intubation in Infants 29 to 35 Weeks' Gestation with Respiratory Distress Syndrome Decreases the Likelihood of Later Mechanical Ventilation: A Randomized Controlled TrialJournal of Perinatology, 2005
- Prophylactic nasal continuous positive airways pressure in newborns of 28–31 weeks gestation: multicentre randomised controlled clinical trialArchives of Disease in Childhood - Fetal and Neonatal Edition, 2004
- Early Extubation and Nasal Continuous Positive Airway Pressure After Surfactant Treatment for Respiratory Distress Syndrome Among Preterm Infants <30 Weeks’ GestationPediatrics, 2004
- Do Clinical Markers of Barotrauma and Oxygen Toxicity Explain Interhospital Variation in Rates of Chronic Lung Disease?Pediatrics, 2000
- Nasal Continuous Positive Airway Pressure and Early Surfactant Therapy for Respiratory Distress Syndrome in Newborns of Less Than 30 Weeks' GestationPediatrics, 1999
- Surfactant Therapy and Nasal Continuous Positive Airway Pressure for Newborns with Respiratory Distress SyndromeNew England Journal of Medicine, 1994